- Wednesday, May 21, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Digital Biomarkers and Biomarkers Market by Product (Consumables, Service), By Type (Biomarkers-Safety, Efficacy, Validation, Digital biomarkers- longitudinal, continuous measurement), By Disease Indication (Cancer, Cardiovascular Disorders), By Application (Diagnostics Development, Drug Discovery and Development, Disease-Risk), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global Digital Biomarkers and Biomarkers Market Overview
The global digital biomarkers and biomarkers market is estimated to reach USD 14.2 billion by 2030, growing at a CAGR of 22.6% during the forecast period of 2022-2030. It was valued at USD 3.6 billion in 2022. Biomarkers refer to biochemical indicators that can mark changes in the structure or function of systems, organs, tissues, cells, and subcellular cells. Biomarkers can reflect normal physiological or pathological processes or drug responses to therapeutic interventions. It plays a role in early diagnosis, disease prevention, drug target determination, drug response, and other aspects. Biomarkers can use alone or in combination with other factors to assess the health or disease state of an individual. Digital biomarkers use to collect data from physiological or therapeutic methods and transform the new data into actionable insights and provide relevant information to the researchers for their better understanding of the disease.Global Digital Biomarkers and Biomarkers Market Insights
Due to the transformation of technology in the medical industry, reduce the risk of chronic diseases, accuracy in collecting data, and measured clinical insights are deriving the market of the digital biomarkers and biomarkers. Whereas, biomarkers have an extensive range of uses and can be used to diagnose diseases, determine the stage of the disease, and evaluate the safety and effectiveness of new drugs or treatments in target populations. For disease research, biomarkers generally refer to a characteristic biochemical indicator in the normal physiological or pathological or therapeutic process that can be objectively measured and evaluated. Moreover, With the adoption of smartphones, the Internet of things, cloud services, and other digital tools have increased the market share of digital biomarkers in the global market. The digital biomarkers help in gathering data of the patient through smartphones. Now, most of the physicians can track their patient’s blood pressure, heart rate, sleep cycle, and others with one single health app in their smartphones. The apps keep the record of the patient body function, and with sensors, it responds in case of any abnormality. Additionally, the data collected from the app helps in interpreting the reports and health status of the patient and also provides accurate data to the clinicians for drawing up in the decision-making process. Moreover, digital biomarkers and markers are a very convenient, cost-effective, and engaging process for the patient. Furthermore, with rising urbanization, people lifestyle has changed and coupled with a growing economy, disposable income has also increased. People have started focusing more on their health and fitness routines. Thus, digital biomarkers are the breakthrough in medical history for providing medical assistance to any person in a cost-effective manner and also reduce the chances of many severe diseases.Growth Driver
Adoption of Smartphones
Digital biomarkers use to collect information and interpret the information to the researcher for a better understanding of both the health of the patient and disease. The adoption of smartphones in the world has fueled the demand for the digital biomarkers as it helps in collecting data of an individual through a healthcare app. The smart alarm or sensors installed in the app allow the individual to keep check of its daily routine and maintain a healthy lifestyle.Biomarkers awareness among people
Biomarkers include early diagnosis or prognostic markers of the disease. Such biomarkers are currently the most widely used and have the most impact, and people are most familiar with them. It can see that biomarkers cover a wide range, and with the advancement of detection technology, more specific detection results as well.By Product Segmental Analysis
Based on product, the global digital biomarkers and biomarkers market bifurcated into Consumables, Service. The service segment gains the largest market share in the global digital biomarkers market. As digital biomarkers account for a larger share in the market and digital biomarkers collect the data from the digital means by taking measures from behavioral, physiological, quantifiable. Thus, smartphones help digital biomarkers help in providing services to the patient. Moreover, in traditional biomarkers, consumables hold the largest market share owing to, low price of consumables and rising market demand.By Type Segmental Analysis
Based on Type, the global digital biomarkers and biomarkers market distributed into Biomarkers-Safety, Efficacy, Validation, and Digital biomarkers- longitudinal, continuous measurement. The efficacy dominated the market value for the biomarkers in the market owing to, rising adoption of biomarkers, a wide variety of products available in the market. Moreover, digital biomarkers account for longitudinal measurement, which captures the largest share in the market. Due to its low cost, easy to use, non-invasive instruments, produce extensive and accurate data helps in fueling the market share of the digital biomarkers.By Disease Indication Segmental Analysis
Based on the disease indication, the global digital biomarkers and biomarkers market bifurcated into Cancer, Cardiovascular Disorders. Cancer has captured the largest market share for the biomarkers in the disease indication market. Biomarkers use for diagnosis of cancer; thus, biomarkers application has been increasing in treating cancer. Moreover, the cardiovascular segment holds the largest share in digital biomarkers; it is mainly due to AR/VR adoption, and development helps in the detection of chronic pain.By Application Segmental Analysis
Based on the Application, the global digital biomarkers and biomarkers market classified into Diagnostics Development, Drug Discovery and Development, Disease-Risk. Diagnostics development has the largest market share in the global digital biomarkers and biomarkers market. The main factors driving growth in this area include personalized and custom-designed treatment for various diseases like cancer and cardiovascular diseases, and neurological disorders have fueled the demand for the digital biomarkers and biomarkers in the global market.By Region Segmental Analysis
Based on geography, the global digital biomarkers and biomarkers market size segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific expected to witness the highest growth during the forecast period. The growing demand for immediate diagnostic testing, changing lifestyle of the people, technology advancement, adoption of smartphone, growing geriatric population. Therefore, these factors will drive the growth of digital biomarkers and biomarkers in the Asia Pacific.Competitor Analysis
Companies such as Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc.other key players in the global Digital Biomarkers and biomarkers market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Digital Biomarkers and Biomarkers manufacturing companies
- Research organizations and consulting companies’ digital biomarkers and biomarkers
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 770.23 Million |
| Revenue forecast in 2027 | USD 11.32 Billion |
| Growth Rate | CAGR of 38.45% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | Qiagen NV, Enzo Biochem, Inc., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc. |
Recent Developments
- In March 2022, Mitsubishi Tanabe Pharma America (MTHA) and Everything ALS, a nonprofit organization dedicated to bridging the gap between patients, technology, and research, teamed up. This partnership seeks to hasten the development of digital biomarkers for amyotrophic lateral sclerosis (ALS).
- In September 2021, JW Bioscience signed a non-exclusive agreement with Immunovia for pancreatic cancer biomarkers.
- In September 2021, Medidata partnered with labcorp to expand decentralized clinical trials for Digital Biomarker Discovery.
- In September 2021, Neuroglee partnered with Mayo Clinic on remote care management for Alzheimer’s.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product- Consumables
- Service
- Biomarkers
- Safety
- Efficacy
- Validation
- Digital biomarkers
- Longitudinal
- Continuous Measurement
- Cancer
- Cardiovascular Disorders
- Diagnostics Development
- Drug Discovery and Development
- Disease-Risk
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Healthcare Fraud Analytics Market
Pharmaceutical Vial Fillers Market
Video Streaming Software Market
Southeast Asia Water Purifier Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Next Generation Biomanufacturing Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product
5.2.1.1. Consumables
5.2.1.2. Service
5.2.2. By Type
5.2.2.1. Biomarkers
5.2.2.1.1. Safety
5.2.2.1.2. Efficacy
5.2.2.1.3. Validation
5.2.2.2. Digital biomarkers
5.2.2.2.1. Longitudinal
5.2.2.2.2. Continuous Measurement
5.2.3. By Disease Indication
5.2.3.1. Cancer
5.2.3.2. Cardiovascular Disorders
5.2.4. By Application
5.2.4.1. Diagnostics Development
5.2.4.2. Drug Discovery and Development
5.2.4.3. Disease-Risk
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia-Pacific
5.2.5.4. South America
5.2.5.5. The Middle East & Africa
- North America Next Generation Biomanufacturing Market Overview
6.1. North America Next Generation Biomanufacturing Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product
6.2.1.1. Consumables
6.2.1.2. Service
6.2.2. By Type
6.2.2.1. Biomarkers
6.2.2.1.1. Safety
6.2.2.1.2. Efficacy
6.2.2.1.3. Validation
6.2.2.2. Digital biomarkers
6.2.2.2.1. Longitudinal
6.2.2.2.2. Continuous Measurement
6.2.3. By Disease Indication
6.2.3.1. Cancer
6.2.3.2. Cardiovascular Disorders
6.2.4. By Application
6.2.4.1. Diagnostics Development
6.2.4.2. Drug Discovery and Development
6.2.4.3. Disease-Risk
6.2.5. By Country
6.2.5.1. US
6.2.5.2. Canada
6.2.5.3. Mexico
6.2.6. Company Market Share (Top 3-5)
6.2.7. Economic Impact Study on North America Next Generation Biomanufacturing Market
- Europe Next Generation Biomanufacturing Market Overview
7.1. Europe Next Generation Biomanufacturing Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product
7.2.1.1. Consumables
7.2.1.2. Service
7.2.2. By Type
7.2.2.1. Biomarkers
7.2.2.1.1. Safety
7.2.2.1.2. Efficacy
7.2.2.1.3. Validation
7.2.2.2. Digital biomarkers
7.2.2.2.1. Longitudinal
7.2.2.2.2. Continuous Measurement
7.2.3. By Disease Indication
7.2.3.1. Cancer
7.2.3.2. Cardiovascular Disorders
7.2.4. By Application
7.2.4.1. Diagnostics Development
7.2.4.2. Drug Discovery and Development
7.2.4.3. Disease-Risk
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. UK
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Rest of Europe
7.2.6. Company Market Share (Top 3-5)
7.2.7. Economic Impact Study on Europe Next Generation Biomanufacturing Market
- Asia-Pacific Next Generation Biomanufacturing Market Overview
8.1. Asia-Pacific Next Generation Biomanufacturing Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product
8.2.1.1. Consumables
8.2.1.2. Service
8.2.2. By Type
8.2.2.1. Biomarkers
8.2.2.1.1. Safety
8.2.2.1.2. Efficacy
8.2.2.1.3. Validation
8.2.2.2. Digital biomarkers
8.2.2.2.1. Longitudinal
8.2.2.2.2. Continuous Measurement
8.2.3. By Disease Indication
8.2.3.1. Cancer
8.2.3.2. Cardiovascular Disorders
8.2.4. By Application
8.2.4.1. Diagnostics Development
8.2.4.2. Drug Discovery and Development
8.2.4.3. Disease-Risk
8.2.5. By Country
8.2.5.1. India
8.2.5.2. Japan
8.2.5.3. Australia
8.2.5.4. Rest of Asia Pacific
8.2.6. Company Market Share (Top 3-5)
8.2.7. Economic Impact Study on Asia Pacific Next Generation Biomanufacturing Market
- South America Next Generation Biomanufacturing Market Overview
9.1. South America Next Generation Biomanufacturing Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product
9.2.1.1. Consumables
9.2.1.2. Service
9.2.2. By Type
9.2.2.1. Biomarkers
9.2.2.1.1. Safety
9.2.2.1.2. Efficacy
9.2.2.1.3. Validation
9.2.2.2. Digital biomarkers
9.2.2.2.1. Longitudinal
9.2.2.2.2. Continuous Measurement
9.2.3. By Disease Indication
9.2.3.1. Cancer
9.2.3.2. Cardiovascular Disorders
9.2.4. By Application
9.2.4.1. Diagnostics Development
9.2.4.2. Drug Discovery and Development
9.2.4.3. Disease-Risk
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Argentina
9.2.5.3. Rest of South America
9.2.6. Company Market Share (Top 3-5)
9.2.7. Economic Impact Study on South America Next Generation Biomanufacturing Market
- The Middle East & Africa Next Generation Biomanufacturing Market Overview
10.1. The Middle East & Africa Next Generation Biomanufacturing Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product
10.2.1.1. Consumables
10.2.1.2. Service
10.2.2. By Type
10.2.2.1. Biomarkers
10.2.2.1.1. Safety
10.2.2.1.2. Efficacy
10.2.2.1.3. Validation
10.2.2.2. Digital biomarkers
10.2.2.2.1. Longitudinal
10.2.2.2.2. Continuous Measurement
10.2.3. By Disease Indication
10.2.3.1. Cancer
10.2.3.2. Cardiovascular Disorders
10.2.4. By Application
10.2.4.1. Diagnostics Development
10.2.4.2. Drug Discovery and Development
10.2.4.3. Disease-Risk
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of the Middle East & Africa
10.2.6. Company Market Share (Top 3-5)
10.2.7. Economic Impact Study on Middle East & Africa Next Generation Biomanufacturing Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Qiagen N.V.
11.7.2. Perkinelmer, Inc.
11.7.3. Merck Millipore
11.7.4. Bio-Rad Laboratories Inc.
11.7.5. Enzo Biochem, Inc.
11.7.6. EKF Diagnostics Holdings, Inc.
11.7.7. Meso Scale Diagnostics LLC.
11.7.8. Biosims Technologies Sas
11.7.9. Cisbio Bioassay
11.7.10. Signosis, Inc
11.7.11. Other Prominent Players
Frequently Asked Questions (FAQ):
Biomarkers are biological state measures that can mark changes in the structure or function of systems, organs, tissues, cells, and subcellular cells.
The global digital biomarkers and biomarkers market is estimated to reach USD 14.2 billion by 2030, and It was valued at USD 3.6 billion in 2022.
The growth rate of the Digital Biomarkers and Biomarkers market is 22.6% during the forecast period.
Biomarkers awareness among people, Adoption of Smartphones are the driving forces of the Digital Biomarkers and Biomarkers market.
By Application, the Digital Biomarkers and Biomarkers market is classified as Diagnostics Development, Drug Discovery and Development, Disease-Risk.
